TYPTF (Entropy Neurodynamics) Tariff Resilience Score: 7/10 (As of Jun. 27, 2026)


What is Entropy Neurodynamics Tariff Resilience Score?

Entropy Neurodynamics TYPTF -45.63% Tariff Resilience Score is 7 as of Jun. 27, 2026. The stock has 5 warning signs investors should review. Among 1,378 Biotechnology companies, Entropy Neurodynamics ranks better than 90.42% on this metric.

Entropy Neurodynamics has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Entropy Neurodynamics has Moderate resilience due to niche pharmaceutical focus. Global supply chain for raw materials, but limited direct impact from tariffs. Historical impacts are minimal, with some pricing power and alternative sourcing options.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Entropy Neurodynamics might have Highly Resilient.

Entropy Neurodynamics  (OTCPK:TYPTF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Entropy Neurodynamics Tariff Resilience Score Related Terms

TYPTF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Entropy Neurodynamics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entropy Neurodynamics Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entropy Neurodynamics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Entropy Neurodynamics's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 7 mean?
Entropy Neurodynamics (TYPTF) has a Tariff Resilience Score of 7 as of Jun. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Entropy Neurodynamics ranks #132 out of 1378 companies in the Biotechnology industry, placing it in the top 9.6%.
Is Entropy Neurodynamics' Tariff Resilience Score too high?
Entropy Neurodynamics' current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. Entropy Neurodynamics' value of 7 is 75% above this industry median. Based on the distribution chart, Entropy Neurodynamics ranks #132 out of 1378 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Entropy Neurodynamics' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Entropy Neurodynamics ranks #132 out of 1378 companies for Tariff Resilience Score. This places Entropy Neurodynamics in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Entropy Neurodynamics' value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,378 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entropy Neurodynamics's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entropy Neurodynamics's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12% above its estimated fair value. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current Tariff Resilience Score is 7 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.